Anaemia in chronic diseases classified elsewhere. Anaemia in chronic diseases classified elsewhere
Conditions
Interventions
Intervention 1: Intervention group: In this study, one group will receive oral iron supplement (furosulfate) 150 mg twice a day for 16 weeks from Obeidi Pharmaceutical Company. The other group of inje
Sponsors
Rasht University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with heart failure Age above 18 years Serum ferritin levels <100 or TS <20% Ferritin 100-300 and hemoglobin below 15
Exclusion criteria
Exclusion criteria: Known and treated anemia Allergy or intolerance to iron supplements Duodenal or gastric ulcer, gastrointestinal disease with impaired iron absorption Oncological diseases History of surgery 6 months before entering the study Active bleeding and the need for blood transfusion in patients with shock or sepsis Unwillingness to continue the study or cause any dissatisfaction in the field of taking iron supplements or participating in the study Acute heart failure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: At the beginning of the study and 16 weeks later. Method of measurement: Minnesota Living With Heart Failure questionnaire.;Function of patients with heart failure. Timepoint: At the beginning of the study and 16 weeks later. Method of measurement: 6 minute walk test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Ahmadnia
Rasht University of Medical Sciences
Outcome results
None listed